Denali Therapeutics (DNLI) FCF Margin (2018 - 2023)
Denali Therapeutics' (DNLI) quarterly FCF Margin came in at 6213.65% in Q3 2023, down 472044.0% year-on-year from N/an in Q3 2022, and down 15691.74% on a QoQ basis from 39.35% in Q2 2023.
Denali Therapeutics (DNLI) FCF Margin (2018 - 2023) Analysis & Trends
Denali Therapeutics (DNLI) has 6 years of FCF Margin data on file, last reported at 6213.65% in Q3 2023.
- On a quarterly basis, FCF Margin fell 472044.0% year-over-year to 6213.65% in Q3 2023; TTM through Jun 2024 was 31736.31%, a 3164776.0% decrease from a year earlier, with the FY2023 full-year figure at 112.22%, up 12070.0% from the prior year.
- FCF Margin for Q3 2023 stood at 6213.65%, down from 39.35% in the prior quarter.
- Over the last five years, FCF Margin for DNLI reached as high as 162.2% in Q4 2020 and fell as low as 106482.69% in Q1 2020.
- Historically, FCF Margin has averaged 6701.87% across 5 years, with a median of 696.66% in 2021.
- Across the five-year window, FCF Margin tumbled 10572426 bps in 2020 and jumped 10581316 bps in 2021, its largest moves.
- Year by year, FCF Margin stood at 881.54% in 2019, then soared by 118 bps to 162.2% in 2020, then sank by 194 bps to 152.03% in 2021, then plunged by 376 bps to 723.79% in 2022, then plunged by 758 bps to 6213.65% in 2023.
- Per Business Quant data, the three most recent FCF Margin figures were 6213.65% in Q3 2023, 39.35% in Q2 2023, and 184.62% in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -6,213.65% |
| Jun 30, 2023 | -39.35% |
| Mar 31, 2023 | -184.62% |
| Dec 31, 2022 | -723.79% |
| Sep 30, 2022 | -1,493.21% |
| Jun 30, 2022 | -94.74% |
| Mar 31, 2022 | -171.38% |
| Dec 31, 2021 | -152.03% |
| Sep 30, 2021 | -780.21% |
| Jun 30, 2021 | -344.33% |
| Mar 31, 2021 | -669.53% |
| Dec 31, 2020 | 162.20% |
| Sep 30, 2020 | 13.29% |
| Jun 30, 2020 | -751.54% |
| Mar 31, 2020 | -106,482.69% |
| Sep 30, 2019 | -881.54% |
| Jun 30, 2019 | -1,068.03% |
| Mar 31, 2019 | -758.43% |
| Dec 31, 2018 | 73.00% |
| Sep 30, 2018 | -3,077.66% |